학술논문

THU-157-Shortened duration pan-genotypic therapy with glecaprevir-pibrentasvir for six weeks among people with acute and recent HCV infection
Document Type
Abstract
Source
In Journal of Hepatology April 2019 70(1) Supplement:e231-e231
Subject
Language
ISSN
0168-8278